mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.004 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.005 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.006 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.006 |